Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|December 19, 2025
Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patientsEmilie Cayssials, Lucie Lefèvre, Amandine Decroos, et al.
Leukemia|May 1, 2015
The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cellsL Mourgues, V Imbert, M Nebout, et al.
Haematologica|September 5, 2007
Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutationFranck E Nicolini, Sandrine Hayette, Selim Corm, et al.
Bone Marrow Transplantation|February 4, 2014
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantationL Gilis, S Morisset, G Billaud, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2016
A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complicationA Conrad, M Le Maréchal, D Dupont, et al.
Leukemia|May 13, 2021
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year updateTimothy P Hughes, Nelma Cristina D Clementino, Mikhail Fominykh, et al.
Frontiers in Cardiovascular Medicine|July 7, 2023
Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experienceM V Matassini, M Marini, A Angelozzi, et al.
Leukemia Research|August 6, 2010
Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patientsSami Joha, Véronique Dauphin, Frédéric Leprêtre, et al.
Cancer|July 26, 2017
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemiaLaurence Legros, Franck E Nicolini, Gabriel Etienne, et al.
Pageof 12